The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation
Open accessAbstract
Objectives The purpose of this study was to assess the safety and efficacy of left atrial appendage (LAA) closure in nonvalvular atrial fibrillation (AF) patients ineligible for warfarin therapy.Background The PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that LAA closure with the Watchman device (Boston Scientific, Natick, Massachusetts) was noninferior to warfarin therapy. However, the PROTECT AF trial only included patients who were candidates for warfarin, and even patients randomly assigned to the LAA closure arm received concomitant warfarin for 6 weeks after Watchman implantation.Methods A multicenter, prospective, nonrandomized study was conducted of LAA closure with the Watchman device in 150 patients with nonvalvular AF and CHADS₂ (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, and prior stroke or transient ischemic attack) score ≥1, who were considered ineligible for warfarin. The primary efficacy endpoint was the combined events of ischemic stroke, hemorrhagic stroke, systemic embolism, and cardiovascular/unexplained death.Results The mean CHADS₂ score and CHA₂DS₂-VASc (CHADS₂ score plus 2 points for age ≥75 years and 1 point for vascular disease, age 65 to 74 years, or female sex) score were 2.8 ± 1.2 and 4.4 ± 1.7, respectively. History of hemorrhagic/bleeding tendencies (93%) was the most common reason for warfarin ineligibility. Mean duration of follow-up was 14.4 ± 8.6 months. Serious procedure- or device-related safety events occurred in 8.7% of patients (13 of 150 patients). All-cause stroke or systemic embolism occurred in 4 patients (2.3% per year): ischemic stroke in 3 patients (1.7% per year) and hemorrhagic stroke in 1 patient (0.6% per year). This ischemic stroke rate was less than that expected (7.3% per year) based on the CHADS₂ scores of the patient cohort.Conclusions LAA closure with the Watchman device can be safely performed without a warfarin transition, and is a reasonable alternative to consider for patients at high risk for stroke but with contraindications to systemic oral anticoagulation. (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology [ASAP]; NCT00851578).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“occlusion may also reduce stroke risk in patients with contraindications to OAC. 454,455”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [454]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,929
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · cited 1×
“In the AVERROES (Apixaban Versus Acetylsalicylic Acid to Prevent Strokes in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment) study, warfarin-ineligible patients were randomly allocated to either aspirin or the factor Xa inhibitor, apixaban (21).”
MethodHolmes, D. R., Reddy, V. Y., Turi, Z. G., Doshi, S. K., Sievert, H., Buchbinder, M., Mullin, C. M., & Sick, P. B. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61343-x · Cited by 2,242
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102 · cited 2×
“Clopidogrel has been reported to reduce ischemic stroke by 32% (13).”
BackgroundMethodMant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Wann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181fa3cf4 · Cited by 1,338
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 726
Go, A. S., Al‐Khatib, S. M., Desvigne-Nickens, P. M., Bansal, N., Bushnell, C., Fang, M. C., Freeman, J. V., Gage, B. F., Hanke, T., Hylek, E. M., et al. (2023) · Stroke · doi:10.1161/strokeaha.121.038273 · Cited by 6
Barssoum, K. N., Khalil, M., Eid, M. M., Hassib, M., Ibrahim, F., Khalife, W. I., Chatila, K., Pandey, R., Abdou, C., Bandyopadhyay, D., et al. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.06.016 · Cited by 6
Ansari, U., Brachmann, J., Lewalter, T., Zeymer, U., Sievert, H., Ledwoch, J., Geist, V., Hochadel, M., Schneider, S., Senges, J., et al. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02376-8 · Cited by 6
Wilson, D., Charidimou, A., & Werring, D. J. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00003 · Cited by 6
Novel Anticoagulants Eliminate the Need for Left Atrial Appendage Exclusion Devices
Ezekowitz, M. D., & Kent, A. P. (2014) · Circulation · doi:10.1161/circulationaha.114.008139 · Cited by 6
Unmasking a naked left atrial appendage closure device: A case of a silent embolic threat
Schiettekatte, S., Czapla, J., Nijs, J., & Meir, M. L. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.10.015 · Cited by 6
Lee, K., Park, S., Kwon, H. J., Kim, I. Y., Yoo, K. H., Lee, S., Park, K., On, Y. K., & Kim, J. S. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.06.013 · Cited by 6
Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility
Swaans, M. J., Wintgens, L. I. S., Alipour, A., Rensing, B. J. M. W., & Boersma, L. V. A. (2016) · Medical Devices Evidence and Research · doi:10.2147/mder.s65492 · Cited by 6
Price, M. J. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.01.002 · Cited by 6
Liu, X., Kleinecke, C., Busch, S., Allakkis, W., Mohrez, Y., Cheikh‐Ibrahim, M., Mahnkopf, C., Brachmann, J., Schnupp, S., Gloekler, S., et al. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14032 · Cited by 6
Left atrial appendage occlusion should be offered only to select atrial fibrillation patients
Munir, M. B., & Hsu, J. C. (2022) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.07.001 · Cited by 6
Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Hemodialysis
Urbanek, L., Heine, G. H., Reddavid, C., Saw, J., Kawamura, I., Reddy, V. Y., Galea, R., Räber, L., Sedaghat, A., Rocca, D. G. D., et al. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.09.038 · Cited by 5
Current evidence and indications for left atrial appendage closure
Shinohara, M., Saji, M., Koike, H., Ohara, H., Enomoto, Y., Nakanishi, R., Fujino, T., & Ikeda, T. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2025.01.014 · Cited by 5
Kow, C. S., Chen, F., Leong, S. K. J., Tham, K. Y., Yeoh, L., Chew, Z. M., Peh, W. J., & Thiruchelvam, K. (2025) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2025.2523920 · Cited by 5
Managing the Left Atrial Appendage in Atrial Fibrillation: Current State of the Art
Khawar, W., Smith, N., & Masroor, S. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.05.036 · Cited by 5
Martínez, C. J., Medina, R. D. C., Robles, P., López, E. B., Serrano, A. V., Gámez, M. A., Campelos-Fernández, P., Sanz, M. S., Ortega, L. M., & Botas, J. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.121.013549 · Cited by 5
Riegler, L., Palermi, S., Scarafile, R., Gioia, R., Pastore, F., Lombardi, A., Marrazzo, G., Ragni, M., Quaranta, G., Sirignano, C., et al. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2204128 · Cited by 5
Gonçalves-Teixeira, P., Costa, T., Fragoso, I., Ferreira, D., Brandao, M., Leite-Moreira, A. F., Sampaio, F., Ribeiro, J., & Fontes‐Carvalho, R. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201362 · Cited by 7
Huang, P., Chiu, F., Cheng, H., Hsu, J.-C., Chua, S., Chu, C., Lin, T., Chen, J., & Tsai, C. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106688 · Cited by 5
Appropriate use criteria of left atrial appendage closure devices: latest evidences
Guarracini, F., Bonvicini, E., Preda, A., Martín, M. J., Muraglia, S., Casagranda, G., Mochen, M., Coser, A., Quintarelli, S., Branzoli, S., et al. (2023) · Expert Review of Medical Devices · doi:10.1080/17434440.2023.2208748 · Cited by 5
Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review
Zhou, X., Zhang, W., Lv, W., Zhou, Q., Li, Y., Zhang, L., Lu, Y., Zhang, J., Xing, Q., Wang, H., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.011 · Cited by 5
Percutaneous Left Atrial Appendage Occlusion
Freixa, X., & Martín‐Yuste, V. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.06.005 · Cited by 5
Maurina, M., Villaschi, A., Pivato, C. A., Mangieri, A., Chiarito, M., Bertoldi, L. F., Briani, M., Fazzari, F., Reimers, B., Regazzoli, D., et al. (2021) · Mini-invasive Surgery · doi:10.20517/2574-1225.2021.88 · Cited by 5
An Overview of Left Atrial Appendage Occlusion Devices
Feldmann, K. J., Arshi, A., & Yakubov, S. J. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0573-0 · Cited by 5
A left atrial appendage closure combined procedure review: Past, present, and future perspectives
Gasperetti, A., Fassini, G. M., Tundo, F., Zucchetti, M., Dessanai, M., & Tondo, C. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13957 · Cited by 5
When to Refer Patients for Left Atrial Appendage Closure
Ellis, C. R., & Jackson, G. G. (2019) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.11.005 · Cited by 5
Karczewski, M., Woźniak, S., Skowronek, R., Burysz, M., Fischer, M., Anisimowicz, L., Demkow, M., Konka, M., & Ogorzeja, W. (2016) · Polish Journal of Cardio-Thoracic Surgery · doi:10.5114/kitp.2016.61041 · Cited by 5
Atrial Fibrillation and Stroke in Elderly Patients
Dang, G., Jahangir, I. A., Sra, J. S., Tajik, A. J., & Jahangir, A. (2016) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.1409 · Cited by 5
WATCHMAN device-related thrombus successfully treated with apixaban
Wong, C., Chan, P., Lam, C.-C., Kwok, O., Lam, Y., & Siu, C. (2017) · Medicine · doi:10.1097/md.0000000000008693 · Cited by 5
Percutaneous retrieval of a dislocated LAmbre left atrial appendage occluder in a canine model
Wang, G., Kong, B., Liu, Y., & Huang, H. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14344 · Cited by 5
Is Antiplatelet Therapy After WATCHMAN Implantation Adequate?
Saw, J. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.02.041 · Cited by 5
NCDR Left Atrial Appendage Occlusion Registry
Lakkireddy, D. R., & Turagam, M. K. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.007 · Cited by 5
Temas de actualidad en arritmias y estimulación cardiaca
García‐Bolao, I., Ruiz‐Mateas, F., Bazán, V., Berruezo, A., Alcalde, Ó., del Ojo, J. L., Acosta, J., Martínez‐Sellés, M., & Mosquera, I. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.11.012 · Cited by 4
Safety and Efficacy of Mini-Invasive Left Atrial Appendage Closure: A Propensity-Score Analysis
Denis, C., Clerfond, G., Chalard, A., Riocreux, C., Pereira, B., Taghli-Lamallem, O., Guizani, T., Catalan, P.-A., Boudias, A., Jean, F., et al. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.021 · Cited by 4
Left atrial appendage occlusion in atrial fibrillation: shaping the future of stroke prevention
Mitsis, A., Eftychiou, C., Samaras, A., Tzikas, A., Fragakis, N., & Kassimis, G. (2025) · Future Cardiology · doi:10.1080/14796678.2025.2484964 · Cited by 4
Kim, M.-R., Dugal, J. K., Wang, S., Taylor, S., Goel, V. S., Shafi, A., Singh, A., & Batra, K. (2025) · Medicine · doi:10.1097/md.0000000000042885 · Cited by 4
Guarracini, F., Martin, M., Marini, M., Branzoli, S., Casagranda, G., Muser, D., Forleo, G. B., Gasperetti, A., Marco, M. D., Guarracini, S., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2305155 · Cited by 4
Wang, S., Zhang, J., Hao, S., Zhu, L., Ning, Z., & Zhao, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.905344 · Cited by 4
Wang, L., Chen, Y., Xu, L., Dai, M., Ke, Y.-J., Wang, B., Zhou, L., Zhang, J., Wu, Z.-Q., Zhou, Y.-J., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1159857 · Cited by 4
Elsheikh, S., Alobaida, M., Bucci, T., Buckley, B. J. R., Gupta, D., Irving, G. J., Hill, A. M., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2024) · Cerebrovascular Diseases · doi:10.1159/000536546 · Cited by 4
Yao, Y., Jin, Q., Zhang, X., & Lv, Q. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-024-00834-7 · Cited by 4
Jommi, C., Iorio, A., Crippa, L., Gelera, A., & Senatore, G. (2013) · PharmacoEconomics Italian Research Articles · doi:10.1007/s40276-013-0008-0 · Cited by 4
Bon usage d’apixaban : que retenir pour la pratique
Albaladejo, P., Deplanque, D., Fossati, F., Mahagne, M., Mismetti, P., Nguyên, P., Roy, P., Touzé, E., & Mourad, J. (2014) · Journal des Maladies Vasculaires · doi:10.1016/j.jmv.2014.09.002 · Cited by 4
Spina, R., & Gunalingam, B. (2014) · Internal Medicine Journal · doi:10.1111/imj.12359 · Cited by 4
New advances in the treatment of atrial fibrillation: focus on stroke prevention
Lau, Y. C., & Lip, G. Y. H. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.948418 · Cited by 4
Left atrial appendage occlusion: 2016 in review
Ramirez, M. D. J. R., Young, B., Harjai, K. J., Mascarenhas, V., & Vijayaraman, P. (2017) · Journal of Interventional Cardiology · doi:10.1111/joic.12410 · Cited by 4
da Costa, M. J. M., Ferreira, E., Quintella, E. F., Amorim, B., Fuchs, A., Zajdenverg, R., Sabino, H. D. C., & de Albuquerque, D. C. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170167 · Cited by 4
Left atrial appendage closure: prevalence and risk of device-associated thrombus formation
Bertog, S. C., & Sievert, H. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2018.10.05 · Cited by 4
Current Endocardial Approaches for Left Atrial Appendage Closure
Rocca, D. G. D., Prete, A. D., Biase, L. D., Horton, R., Al‐Ahmad, A., Bassiouny, M., Mohanty, S., Trivedi, C. G., Romero, J. E., Gianni, C., et al. (2019) · European Journal of Arrhythmia & Electrophysiology · doi:10.17925/ejae.2019.5.1.40 · Cited by 4
Epicardial versus Endocardial Closure
Akella, K., Yarlagadda, B., Murtaza, G., Rocca, D. G. D., Gopinathannair, R., Natale, A., & Lakkireddy, D. (2020) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.11.011 · Cited by 4
Kook, H., Kim, H.-D., Uhm, J., Kim, Y., Kim, J., Pak, H., Lee, H., Choi, R. K., Kang, W. C., Shin, E., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244723 · Cited by 4
Tsai, C., Huang, P., Chiu, F.-C., Chen, J.-J., Chang, S.-N., Hsu, J.-C., Chua, S., Cheng, H., Hwang, J., Hwang, J.-J., et al. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02085-0 · Cited by 4
Percutaneous left atrial appendage closure with the Watchman device: a systematic review
Maksym, J., Grabowski, M., & Mazurek, T. (2024) · Advances in Interventional Cardiology · doi:10.5114/aic.2024.136406 · Cited by 4
Der katheterbasierte Verschluss des linken Vorhofohrs
Skurk, C., Leistner, D. M., Park, J.-W., & Landmesser, U. (2016) · Der Internist · doi:10.1007/s00108-016-0113-z · Cited by 4
Preserving Cognitive Function in Patients with Atrial Fibrillation.
Lin, T., Wißner, E., Tilz, R. R., Rillig, A., Mathew, S., Rausch, P., Rausch, P., Lemeš, C., Deiß, S., Kamioka, M., et al. (2014) · PubMed Central · doi:10.4022/jafib.980 · Cited by 4
Zeng, Q., Cheng, Z., Xia, Y., Cheng, R., Ou, A., Xinrui, L., Xu, X., Huang, Y., & Xu, D. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320949068 · Cited by 4
Long-Term Safety and Efficacy of Percutaneous Left Atrial Appendage Closure with the LAmbre Device
Wang, G., Kong, B., Liu, Y., & Huang, H. (2020) · Journal of Interventional Cardiology · doi:10.1155/2020/6613683 · Cited by 4
Bolao, I. G., Calvo, N., Macı́as, A., Barba, J., Salterain, N., Ramos, P., Ballesteros, G., & Neglia, R. (2016) · PubMed Central · doi:10.4022/jafib.1346 · Cited by 4
Device-Related Thrombus After Left Atrial Appendage Occlusion With the Amulet Device
Peyrol, M., Cautela, J., Salaün, E., Miola, C., Franceschi, F., Thuny, F., Pinto, J., Laine, M., Maximovitch, A., Paganelli, F. F., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.08.022 · Cited by 4
Price, M. J., Lerner, D., Rastogi, A., Romero, S., Smith, M. R., Rubenson, D. S., Funk, J., Janzcyk, G., Edwards-Mobley, M., Wheeler, C. M., et al. (2020) · Structural Heart · doi:10.1080/24748706.2020.1766162 · Cited by 4
Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion Using the WATCHMAN Device
Pacha, H. M., Hritani, R., & Alraies, M. C. (2018) · Ochsner Journal · doi:10.31486/toj.18.0012 · Cited by 4
Tzikas, A., Freixa, X., & Ibrahim, R. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.846216 · Cited by 4
Left Atrial Appendage Occlusion Device–Related Thrombus
Valderrábano, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.077 · Cited by 4
Tung, M. L., & Chen, T. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.03.004 · Cited by 4
Primeßnig, U., Schrader, H., Wiedenhofer, J. M., Trippel, T. D., Parwani, A. S., Blaschke, F., Hindricks, G., Falk, V., Dreger, H., Sherif, M., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1401974 · Cited by 3
Antithrombotic therapy after left atrial appendage occlusion
Raffo, C., Greco, A., & Capodanno, D. (2025) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2025.2486154 · Cited by 3
d’Entremont, M.-A., Healy, J., & Jolly, S. S. (2025) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001270 · Cited by 3
Laterra, G., Scalia, L., Strazzieri, O., Agnello, F. G., Reddavid, C., Ingala, S., Russo, D., Barbera, C., Guarino, S., Vizzari, G., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15093396 · Cited by 3
Effectiveness and safety of transcatheter left atrial appendage closure
Nakajima, Y. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.08.031 · Cited by 3
Cerebral Embolic Protection: Is There a Benefit for Left Atrial and Mitral Valve Procedures?
Besir, B., & Kapadia, S. R. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02132-4 · Cited by 3
Cerebrovascular Management Considerations in Patients on AATs
Ryan, D., Feng, W., & Liu, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103420 · Cited by 4
Mahon, C., Keane, D., & Erwin, J. (2015) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2015.05.012 · Cited by 3
The future of left atrial appendage occlusions: When extraordinary claims require evidence…
Thambo, J., & Renou, P. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.09.003 · Cited by 3
Dealing With the Left Atrial Appendage for Stroke Prevention: Devices and Decision-Making
Phillips, K. P., & Paul, V. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.113 · Cited by 3
Percutaneous left atrial appendage closure for managing thromboembolic risk in atrial fibrillation
Khan, F., Ramirez, F. D., & Hibbert, B. M. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.180470 · Cited by 3
D’Ancona, G., Ketterer, U., Kische, S., Murero, M., Feickert, S., Ortak, J., Öner, A. Ö., & İnce, H. (2020) · Future Cardiology · doi:10.2217/fca-2019-0086 · Cited by 4
Plugs for left atrial appendage occlusion: an overview of available devices
Obeid, S. N., Nietlispach, F., & Meier, B. (2020) · Expert Review of Medical Devices · doi:10.1080/17434440.2020.1837621 · Cited by 3
Peri- and Post-procedural Anticoagulation with Left Atrial Appendage Occlusion Devices
Pradyumna, A., & Pujari, S. H. (2023) · Heart International · doi:10.17925/hi.2023.17.1.54 · Cited by 4
Batko, J., Litwinowicz, R. A., Kapelak, B., & Bartuś, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237417 · Cited by 3
Antithrombotic Management After Intracranial Hemorrhage
Cajavilca, C. E., Hooper, D., Imran, R., & Gadhia, R. R. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0771-y · Cited by 3
Maarse, M., Swaans, M. J., & Boersma, L. V. A. (2019) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.10.002 · Cited by 3
Watchman Device: Left Atrial Appendage Closure For Stroke Prophylaxis In Atrial Fibrillation.
Obeyesekere, M. (2014) · PubMed Central · doi:10.4022/jafib.1099 · Cited by 3
Tandar, A., Nielsen, J., & Whisenant, B. K. (2020) · Structural Heart · doi:10.1080/24748706.2020.1834173 · Cited by 4
Lasek‐Bal, A., & Mizia‐Stec, K. (2015) · Advances in Interventional Cardiology · doi:10.5114/pwki.2015.49179 · Cited by 3
The WATCHMAN device for stroke prophylaxis in atrial fibrillation: an evolving niche
Couch, G., & Sabir, I. N. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1000795 · Cited by 3
Decennial Analysis of Interventional Left Atrial Appendage Closure
Schmidt, B., Bordignon, S., Fuernkranz, A., Perrotta, L., Scherer, D., & Chun, K. R. J. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12704 · Cited by 3
Kiani, J. G., & Holmes, D. R. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0542-5 · Cited by 3
Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation
Le, D. L., Morelli, R., Badhwar, N., & Lee, R. J. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1057123 · Cited by 3
Percutaneous left atrial appendage occlusion: New perspectives for the method
Gorczyca−Michta, I., & Wożakowska−Kapłon, B. (2017) · Cardiology Journal · doi:10.5603/cj.a2017.0029 · Cited by 3
Alipour, A., Wintgens, L. I. S., Swaans, M. J., Balt, J. C., Rensing, B. J. W. M., & Boersma, L. V. A. (2017) · Vascular Health and Risk Management · doi:10.2147/vhrm.s89213 · Cited by 3
Verschluss des linken Vorhofohrs bei nichtvalvulärem Vorhofflimmern
Häusler, K. G., Endres, M., & Landmesser, U. (2018) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-018-0500-4 · Cited by 3
Left Atrial Appendage Occlusion in the Management of Stroke in Patients With Atrial Fibrillation
Ojo, A. O., Yandrapalli, S., Veseli, G., Karim, M., Aronow, W. S., Sharma, M., Frishman, W. H., Naidu, S. S., Jacobson, J. T., & Iwai, S. (2018) · Cardiology in Review · doi:10.1097/crd.0000000000000240 · Cited by 3
Management von intrazerebralen Blutungen unter oraler Antikoagulation
Sembill, J. A., Kuramatsu, J. B., Hohnloser, S. H., & Huttner, H. B. (2019) · Herz · doi:10.1007/s00059-019-4802-y · Cited by 3
Haddad, A., Bocchese, M., Garber, R., O'Neill, B. P., Yesenosky, G. A., Patil, P. V., Keane, M. G., Islam, S., Sherrer, J., Basil, A. K., et al. (2021) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14255 · Cited by 3
Diagnosis and Management of Ischemic Stroke
Khaja, A. M. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_18 · Cited by 3
Charidimou, A., & Werring, D. J. (2013) · European Journal of Neurology · doi:10.1111/ene.12258 · Cited by 3
Percutaneous Left Atrial Appendage Suture Ligation
Dagres, N., Rolf, S., & Hindricks, G. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.031 · Cited by 3
Peri-Device Leak After Left Atrial Appendage Occlusion
Gabriels, J. K., & Liu, C. F. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.04.008 · Cited by 3
Zenger, B., Kolomaya, A. E., Ranjan, R., Bunch, T. J., & Steinberg, B. A. (2025) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-025-02096-7 · Cited by 2
Torres-Iglesias, R., Teruel, L., Sánchez-Corral, M. A., Cerdà, P., Villanueva, B., Gamundí, E., Peláez, P., Moreno-Lopes, S., Iriarte, A., Alba, E., et al. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106695 · Cited by 2
Metadata
- Authors
- Reddy, V. Y., Möbius-Winkler, S., Miller, M. A., Neuzil, P., Schuler, G., Wiebe, J., Sick, P., & Sievert, H.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Leipzig Heart Institute (DE)
- Cardiovascular Center Frankfurt (DE)
- Krankenhaus Barmherzige Brüder (DE)
- Corresponding author
- Reddy, Vivek Y.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 61
- Issue
- 25
- Pages
- 2551-2556
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2115996784
- Cited by
- 727
- References
- 31
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 46 · 2023: 51 · 2022: 43 · 2021: 57 · 2020: 48 · 2019: 59 · 2018: 61 · 2017: 72 · 2016: 83 · 2015: 75 · 2014: 59 · 2013: 17
- FWCI
- 52.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Boston Scientific
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- left atrial appendage closure, Watchman device, non-valvular atrial fibrillation, stroke prevention, systemic embolism, CHADS2 score, CHA2DS2-VASc score, bleeding risk, procedural safety, ischemic stroke, hemorrhagic stroke, anticoagulation alternatives
- MeSH terms
- Contraindications, Clopidogrel, Administration, Oral, Aged, Aged, 80 and over, Anticoagulants, Feasibility Studies, Female, Follow-Up Studies, Humans, Male, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Atrial Appendage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
